Lapatinib
NDC 0480-3237, Lapatinib, tablet, film coated, from Teva Pharmaceuticals, Inc..
- Product NDC
- 0480-3237
- Status
- Listed
- Labeler
- Teva Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217968
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAPATINIB DITOSYLATE250 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0480-3237-51 | 00480323751 | 150 TABLET, FILM COATED in 1 BOTTLE (0480-3237-51) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b09abf73-1eef-4e12-b400-c030d546d223
Use it
Look up 0480-3237 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0480-3237. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.